Literature DB >> 822668

The development of a radioimmunoassay for arginine vasopressin.

H D Freisenhausen, H Frahm, T Cabrijan, G Wiethold.   

Abstract

The development of a sensitive and specific radioimmunoassay for vasopressin is described. Antibodies were successfully produced following the coupling of synthetic arginine vasopressin with bovine serum albumin carried out with carbodiimide. In order to standardize the assay, the labelled hormone has to be separated twice using a DEAE-Sephadex-A-25 column and thin layer chromatography with cellulose plates. A further condition to obtain a reproducible standard curve is the use of a pure arginine vasopressin checked by cellulose chromatography. Most of the vasopressin batches available do not fulfil this requirement of purity. With the method described, vasopressin can be determined in unextracted human urine. The lower limit of detection is 2 pg/ml. Normal values are in the range of 67.5 +/- 34.3 ng/24 h (kappa +/- SD, n =45). No significant difference of AVP excretion was found between men and women. The usefulness of the assay is demonstrated in patients with hypothalamic or pituitary disorders.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822668     DOI: 10.1530/acta.0.0830050

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Bioanalytical inaccuracy: a threat to the integrity and efficiency of research.

Authors:  Simon N Young; George N Anderson
Journal:  J Psychiatry Neurosci       Date:  2010-01       Impact factor: 6.186

2.  Production of porcine antibodies with high specificity to [8-D-arginine] deamino-vasopressin (dDAVP).

Authors:  J Slaininová; T Barth; F Franĕk
Journal:  Experientia       Date:  1977-12-15

3.  Urinary excretion of immunoreactive vasopressin in prepubertal children. Lack of correlation with urinary excretion of immunoreactive neurophysins.

Authors:  A M Allevard-Burguburu; G Geelen; B Semporé; F Louis; J J Legros; C Gharib
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.